Simplex Trading
MIRM icon

Simplex Trading’s Mirum Pharmaceuticals MIRM Stock Holding History

Simplex Trading’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37K Buy
+400
New +$37.6K ﹤0.01% 6177
2025
Q2 		– Sell
-700
Closed -$31K – 9317
2025
Q1 		$31K Buy
+700
New +$33K ﹤0.01% 6221
2024
Q4 		– Sell
-2,000
Closed -$78K – 9188
2024
Q3 		$78K Buy
2,000
+600
+43% +$23.9K ﹤0.01% 5467
2024
Q2 		$47K Sell
1,400
-900
-39% -$23.6K ﹤0.01% 6155
2024
Q1 		$57K Sell
2,300
-15,600
-87% -$429K ﹤0.01% 6145
2023
Q4 		$528K Buy
17,900
+10,100
+129% +$306K ﹤0.01% 3642
2023
Q3 		$246K Buy
7,800
+1,600
+26% +$43.8K ﹤0.01% 4133
2023
Q2 		$160K Buy
+6,200
New +$165K ﹤0.01% 4559
2023
Q1 		– Sell
-100
Closed -$1K – 9716
2022
Q4 		$1K Sell
100
-400
-80% -$7.91K ﹤0.01% 8865
2022
Q3 		$10K Buy
+500
New +$12K ﹤0.01% 8246
2022
Q1 		– Sell
-900
Closed -$14K – 11022
2021
Q4 		$14K Buy
+900
New +$14K ﹤0.01% 8752

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Simplex Trading's MIRM Position: Q1 2026 in Review

Simplex Trading opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2026: 303 shares worth $28K. The stake represents ﹤0.01% of the portfolio and ranks #6458 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MIRM as recently as Q1 2024.

Simplex Trading first reported a position in MIRM in Q4 2021 and has held it in 7 quarters since. The position peaked at $177K in Q4 2023. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Simplex Trading held 303 shares of Mirum Pharmaceuticals worth $28K as of Q1 2026.
  • Mirum Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6458 holding.
  • Simplex Trading first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • Simplex Trading's Mirum Pharmaceuticals position peaked at $177K in Q4 2023.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.